Satish Mocherla

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial”.

Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial

The Lancet Respiratory Medicine(2021)10.1016/s2213-2600(21)00384-2

N/A

4.4DataRank · unranked

167 citations

Aneesh K Mehta, Thomas F Patterson, Nathaniel Erdmann, Carlos A Gomez, Mamta K Jain +95 more

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

The Lancet Respiratory Medicine(2022)10.1016/s2213-2600(22)00088-1

N/A

3.0DataRank · unranked

128 citations

Kay M Tomashek, Thomas F. Patterson, Carlos A. Gómez, Vincent C. Marconi, Mamta K. Jain +95 more